Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Secured Capital is a prominent investment and private equity firm, historically recognized for its significant presence in real estate and asset management, particularly in the Asian markets through its association with PAG (Pacific Alliance Group). While the name frequently appears in life science and biotech news, it is almost exclusively used as a descriptive phrase referring to the successful acquisition of funding by various pharmaceutical companies rather than as a standalone biotech entity. The firm focuses on opportunistic investments, debt restructuring, and real estate finance. It does not maintain a drug development pipeline or therapeutic focus in the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Secured Capital.